StockComparison Logo
vs

EHAB vs CADL

Comparison between Enhabit, Inc. (EHAB, Company) and Candel Therapeutics Inc (CADL, Company).

Both EHAB and CADL are from the Healthcare sector.

EHAB vs CADL - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
EHAB
$707M
CADL
$706M
Max Drawdown
Winner
EHAB
71.33%
CADL
94.33%
Sharpe Ratio
EHAB
0.76
Winner
CADL
0.88
Industry
EHAB
Medical Care Facilities
CADL
Biotechnology
P/E Ratio
EHAB
13.15
Winner
CADL
-10.14
Forward P/E
Winner
EHAB
23.75
CADL
43.48
Debt to Equity
EHAB
0.00%
CADL
0.00%
Free Cash Flow Yield
Winner
EHAB
11.45%
CADL
-6.94%
P/S Ratio
EHAB
N/A
CADL
436.42
P/B Ratio
EHAB
N/A
CADL
5.24

EHAB vs CADL - Historical Returns

Returns include dividend reinvestment.

1M
EHAB
-1.00%
Winner
CADL
+11.69%
3M
EHAB
+23.66%
Winner
CADL
+46.00%
6M
Winner
EHAB
+70.58%
CADL
+62.22%
1Y
EHAB
+30.43%
Winner
CADL
+55.56%
5Y(CAGR)
EHAB
N/A
CADL
+7.89%
Max(CAGR)
EHAB
-12.11%
Winner
CADL
+7.89%

EHAB vs CADL - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearEHABCADL
2026+51.82%+87.87%
2025+18.97%-37.15%
2024-23.13%+498.62%
2023-20.51%-16.95%
2022-42.13%-77.62%
2021N/A+11.71%

EHAB vs CADL Drawdown Comparison

The maximum drawdown for EHAB was -71.33%, occurring on Aug 1, 2025. This drawdown has not yet recovered.

The maximum drawdown for CADL was -94.33%, occurring on Nov 3, 2023. Recovery took 641 trading sessions.

The current EHAB drawdown is -39.31%. The current CADL drawdown is -27.00%.

RankEHABCADL
#1-71.33%
Jul 1, 2022 - Aug 1, 2025
-94.33%
Oct 26, 2021 - May 15, 2024
#2N/A-72.86%
May 15, 2024 - Nov 15, 2024
#3N/A-36.31%
Sep 8, 2021 - Oct 26, 2021
#4N/A-31.95%
Aug 11, 2021 - Sep 7, 2021
#5N/A-1.57%
Jul 27, 2021 - Jul 29, 2021
#6N/A-1.19%
Jul 30, 2021 - Aug 10, 2021

Correlation

Correlation between EHAB and CADL is -0.43 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.43
-101

Select Stocks to Compare